86 related articles for article (PubMed ID: 23686102)
1. Predictability of peripheral lymphocyte reduction of novel S1P1 agonists by in vitro GPCR signaling profile.
Xu H; McElvain M; Fiorino M; Henkle B; Sherman L; Xu Y; Tominey E; Kelley K; Adlam M; Bürli R; Siu J; Wong M; Cee VJ
J Biomol Screen; 2013 Oct; 18(9):997-1007. PubMed ID: 23686102
[TBL] [Abstract][Full Text] [Related]
2. beta-Arrestin recruitment assay for the identification of agonists of the sphingosine 1-phosphate receptor EDG1.
van Der Lee MM; Bras M; van Koppen CJ; Zaman GJ
J Biomol Screen; 2008 Dec; 13(10):986-98. PubMed ID: 19036707
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine-1-phosphate-induced Flk-1 transactivation stimulates mouse embryonic stem cell proliferation through S1P1/S1P3-dependent β-arrestin/c-Src pathways.
Ryu JM; Baek YB; Shin MS; Park JH; Park SH; Lee JH; Han HJ
Stem Cell Res; 2014 Jan; 12(1):69-85. PubMed ID: 24145189
[TBL] [Abstract][Full Text] [Related]
4. Sphingosine-1-phosphate (S1P) displays sustained S1P1 receptor agonism and signaling through S1P lyase-dependent receptor recycling.
Gatfield J; Monnier L; Studer R; Bolli MH; Steiner B; Nayler O
Cell Signal; 2014 Jul; 26(7):1576-88. PubMed ID: 24704119
[TBL] [Abstract][Full Text] [Related]
5. S1P
Birker-Robaczewska M; Bolli M; Rey M; de Kanter R; Kohl C; Lescop C; Boucher M; Poirey S; Steiner B; Nayler O
Mol Pharmacol; 2018 Feb; 93(2):109-118. PubMed ID: 29203519
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine-1-phosphate receptors control B-cell migration through signaling components associated with primary immunodeficiencies, chronic lymphocytic leukemia, and multiple sclerosis.
Sic H; Kraus H; Madl J; Flittner KA; von Münchow AL; Pieper K; Rizzi M; Kienzler AK; Ayata K; Rauer S; Kleuser B; Salzer U; Burger M; Zirlik K; Lougaris V; Plebani A; Römer W; Loeffler C; Scaramuzza S; Villa A; Noguchi E; Grimbacher B; Eibel H
J Allergy Clin Immunol; 2014 Aug; 134(2):420-8. PubMed ID: 24679343
[TBL] [Abstract][Full Text] [Related]
7. Investigating the molecular mechanisms through which FTY720-P causes persistent S1P1 receptor internalization.
Sykes DA; Riddy DM; Stamp C; Bradley ME; McGuiness N; Sattikar A; Guerini D; Rodrigues I; Glaenzel A; Dowling MR; Mullershausen F; Charlton SJ
Br J Pharmacol; 2014 Nov; 171(21):4797-807. PubMed ID: 24641481
[TBL] [Abstract][Full Text] [Related]
8. c-Src is involved in regulating signal transmission from PDGFbeta receptor-GPCR(s) complexes in mammalian cells.
Waters CM; Connell MC; Pyne S; Pyne NJ
Cell Signal; 2005 Feb; 17(2):263-77. PubMed ID: 15494217
[TBL] [Abstract][Full Text] [Related]
9. Reassessment of the pharmacology of Sphingosine-1-phosphate S1P3 receptor ligands using the DiscoveRx PathHunter™ and Ca2+ release functional assays.
Riddy DM; Stamp C; Sykes DA; Charlton SJ; Dowling MR
Br J Pharmacol; 2012 Oct; 167(4):868-80. PubMed ID: 22577868
[TBL] [Abstract][Full Text] [Related]
10. No differences observed among multiple clinical S1P1 receptor agonists (functional antagonists) in S1P1 receptor down-regulation and degradation.
Lukas S; Patnaude L; Haxhinasto S; Slavin A; Hill-Drzewi M; Horan J; Modis LK
J Biomol Screen; 2014 Mar; 19(3):407-16. PubMed ID: 24003058
[TBL] [Abstract][Full Text] [Related]
11. Endocytosis of Ligand-Activated Sphingosine 1-Phosphate Receptor 1 Mediated by the Clathrin-Pathway.
Reeves PM; Kang YL; Kirchhausen T
Traffic; 2016 Jan; 17(1):40-52. PubMed ID: 26481905
[TBL] [Abstract][Full Text] [Related]
12. Different response patterns of several ligands at the sphingosine-1-phosphate receptor subtype 3 (S1P(3)).
Jongsma M; van Unen J; van Loenen PB; Michel MC; Peters SL; Alewijnse AE
Br J Pharmacol; 2009 Apr; 156(8):1305-11. PubMed ID: 19309361
[TBL] [Abstract][Full Text] [Related]
13. Multiple signaling routes involved in the regulation of adenylyl cyclase and extracellular regulated kinase by dopamine D(2) and D(3) receptors.
Jin M; Min C; Zheng M; Cho DI; Cheong SJ; Kurose H; Kim KM
Pharmacol Res; 2013 Jan; 67(1):31-41. PubMed ID: 23059541
[TBL] [Abstract][Full Text] [Related]
14. FTY720 Phosphate Activates Sphingosine-1-Phosphate Receptor 2 and Selectively Couples to Gα12/13/Rho/ROCK to Induce Myofibroblast Contraction.
Sobel K; Monnier L; Menyhart K; Bolinger M; Studer R; Nayler O; Gatfield J
Mol Pharmacol; 2015 Jun; 87(6):916-27. PubMed ID: 25762025
[TBL] [Abstract][Full Text] [Related]
15. Utilization of the Tango beta-arrestin recruitment technology for cell-based EDG receptor assay development and interrogation.
Wetter JA; Revankar C; Hanson BJ
J Biomol Screen; 2009 Oct; 14(9):1134-41. PubMed ID: 19726785
[TBL] [Abstract][Full Text] [Related]
16. Sphingosine-1-phosphate signaling in physiology and diseases.
Takuwa Y; Okamoto Y; Yoshioka K; Takuwa N
Biofactors; 2012; 38(5):329-37. PubMed ID: 22674845
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors.
Osinde M; Mullershausen F; Dev KK
Neuropharmacology; 2007 Apr; 52(5):1210-8. PubMed ID: 17379261
[TBL] [Abstract][Full Text] [Related]
18. S1P1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate.
Jo E; Sanna MG; Gonzalez-Cabrera PJ; Thangada S; Tigyi G; Osborne DA; Hla T; Parrill AL; Rosen H
Chem Biol; 2005 Jun; 12(6):703-15. PubMed ID: 15975516
[TBL] [Abstract][Full Text] [Related]
19. Kappa opioid receptor screen with the Tango beta-arrestin recruitment technology and characterization of hits with second-messenger assays.
Doucette C; Vedvik K; Koepnick E; Bergsma A; Thomson B; Turek-Etienne TC
J Biomol Screen; 2009 Apr; 14(4):381-94. PubMed ID: 19403921
[TBL] [Abstract][Full Text] [Related]
20. Biasing the parathyroid hormone receptor: relating in vitro ligand efficacy to in vivo biological activity.
Appleton KM; Lee MH; Alele C; Alele C; Luttrell DK; Peterson YK; Morinelli TA; Luttrell LM
Methods Enzymol; 2013; 522():229-62. PubMed ID: 23374189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
